DATA: 23/03/2020
Le videoriprese del X Congresso Nazionale IG-IBD sono state realizzate grazie al contributo non condizionante di
THURSDAY, 28TH NOVEMBER
|
|
| 14.30 - 15.00 | Lecture: Microbioma and Immune System Interaction H. Sokol Slides |
|
ORAL COMMUNICATIONS |
|
| 15.00 - 15.10 | PREVALENCE OF ANAEMIA IN INFLAMMATORY BOWEL DISEASE: PRELIMINARY RESULTS OF THE OBSERVATIONAL ITALIAN MULTICENTRE IG-IBD STUDY RIDART 1 M.V. Lenti Slides |
| 15.20 - 15.30 | HUMAN CYTOMEGALOVIRUS AND EPSTEIN-BARR VIRUS SPECIFIC T-CELL IMMUNITY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE C. Mengoli Slides |
| 15.30 - 15.40 | SERUM PCSK9 AS NOVEL BIOMARKER FOR INFLAMMATION AND CARDIOVASCULAR RISK IN ULCERATIVE COLITIS C. Marinelli Slides |
| 15.40 - 15.50 | PREVALENCE OF INFECTIONS IN PATIENTS AFFECTED BY INFLAMMATORY BOWEL DISEASE TREATED WITH ANTI-TNF-ALPHA AGENTS: A SINGLE-CENTER EXPERIENCE N. Imperatore Slides |
| 15.50 - 16.00 | THERAPEUTIC DRUG MONITORING IN CROHN’S DISEASE PATIENTS, A COMPARISON BETWEEN HOMOGENEOUS MOBILITY SHIFT ASSAY AND POINT OF CARE METHOD M.G. Demarzo Slides |
|
SESSION II: “MEDICAL THERAPY IN REFRACTORY IBD: WHEN ENOUGH IS ENOUGH?”
|
|
| 17.45 - 18.05 | Crohn disease A. Rispo Slides |
| 18.05 - 18.25 | Ulcerative colitis S. Renna Slides |
| 18.25 - 18.45 | Refractory pouchitis F. Rizzello Slides |
|
FRIDAY, 29TH NOVEMBER
|
|
| 08.30 - 09.00 | Lecture: Microscopic Colitis current management D. Guagnozzi Slides |
|
ORAL COMMUNICATIONS |
|
| 09.00 - 09.10 | ARE WE CHOOSING WISELY IN INFLAMMATORY BOWEL DISEASE CARE? THE IG-IBD CHOOSING WISELY CAMPAIGN M.V. Lenti Slides |
| 09.10 - 09.20 | TEN-YEARS DATA FROM THE PEDIATRIC INFLAMMATORY BOWEL DISEASE SIGENP REGISTRY P. Alvisi Slides |
| 09.20 - 09.30 | ASSOCIATION BETWEEN HISTOLOGICAL INDICES AND ULCERATIVE COLITIS ACTIVITY MEASURES AMONG PATIENTS IN THE HICKORY (ETROLIZUMAB) OPEN-LABEL COHORT A. Armuzzi Slides |
| 09.30 - 09.40 | PREVALENCE AND RISK FACTORS FOR SLEEP DISTURBANCE IN INFLAMMATORY BOWEL DISEASE- A CROSS SECTIONAL STUDY C. Marinelli Slides |
| 09.40 - 09.50 | STIGMATISATION AND RESILIENCE IN INFLAMMATORY BOWEL DISEASE. RESULTS FROM AN ITALIAN, SINGLE-CENTRE, LONGITUDINAL STUDY M.V. Lenti Slides |
| 09.50 - 10.00 | HIGH FREQUENCY OF UNDIAGNOSED MENTAL ILLNESS IN INFLAMMATORY BOWEL DISEASES I. Marafini Slides |
|
SESSION IV: FUTURE BENCHMARKS IN IBD
|
|
| 11.15 - 11.35 | Diet and food additivies in IBD: foe or friend? K. Gerasimidis Slides |
| 11.35 - 11.55 | Disability in IBD F. Castiglione Slides |
| 11.55 - 12.15 | Standars of care in IBD G. Fiorino Slides |
|
SESSION V |
|
| 15.00 - 15.30 | Lecture: Acute Severe Ulcerative Colitis A. Kohn Slides |
|
ORAL COMMUNICATIONS
|
|
| 15.30 - 15.40 | CLINICAL AND EPIDEMIOLOGICAL FEATURES OF ULCERATIVE COLITIS PATIENTS IN SARDINIA, ITALY – RESULTS FROM A MULTICENTER STUDY G. Mocci Slides |
| 15.40 - 15.50 | QUALITY OF LIFE AND PERCEPTION OF CARE FOR ULCERATIVE COLITIS PATIENTS IN SARDINIA: RESULTS OF A MULTICENTER OBSERVATIONAL STUDY G. Mocci Slides |
| 15.50 - 16.00 | RESULTS OF A RETROSPECTIVE IGIBD STUDY ON ADALIMUMAB USE IN REAL PRACTICE IN ITALY: THE REAL-LIFE CLINICAL EFFECTIVENESS OF ADALIMUMAB IN ULCERATIVE COLITIS (REALADA-UC) STUDY A. Vitello Slides |
| 16.00 - 16.10 | EFFECTIVENESS, SAFETY AND IMMUNOGENICITY OF SWITCHING FROM ORIGINATOR INFILIXIMAB TO BIOSIMILAR IN A LARGE COHORT OF IBD PATIENTS G. Privitera Slides |
| 16.10 - 16.20 | A PROPENSITY SCORE-WEIGHTED COMPARISON OF VEDOLIZUMAB AND ADALIMUMAB IN CROHN’S DISEASE: REAL-LIFE DATA FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (SN-IBD) F.S. Macaluso Slides |
| 16.20 - 16.30 | FECAL MICROBIOTA TRANSPLANTATION CONTROLS MURINE CHRONIC INTESTINAL INFLAMMATION BY MODULATING IMMUNE CELL FUNCTIONS AND GUT MICROBIOTA COMPOSITION. M.R. Giuffrè Slides |
|
SESSION VI |
|
| 17.00 - 18.30 | Common errors in the management of IBD Case presentation & discussants C. Bezzio, D. Pugliese Slides |
|
SATURDAY, 30TH NOVEMBER
|
|
| 09.00 - 09.10 | SURGICAL PREVENTION OF ANASTOMOTIC RECURRENCE BY EXCLUDING MESENTERY IN CROHN’S DISEASE: THE SUPREME-CD STUDY. G. Luglio Slides |
| 09.10 - 09.20 | FEASIBILITY AND SAFETY OF STRICTUREPLASTIES PERFORMED BY LAPAROSCOPIC APPROACH FOR COMPLICATED CROHN’S DISEASE. A PROSPECTIVE, OBSERVATIONAL, COHORT STUDY. G.M. Sampietro Slides |
| 09.20 - 09.30 | RISK FACTORS AND PROGNOSTIC SIGNIFICANCE OF JOINT MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE PATIENTS: APPLICATION OF THE STRII QUESTIONNAIRE D.G. Ribaldone Slides |
| 09.30 - 09.40 | DIAGNOSTIC ACCURACY OF VIRTUAL CHROMOENDOSCOPY WITH NARROW BAND IMAGING (NBI) FOR THE CLASSIFICATION OF POLYPOID AND NON-POLYPOID LESIONS IN ULCERATIVE COLITIS: A PROSPECTIVE STUDY USING DIFFERENT ENDOSCOPIC CLASSIFICATIONS A. Cassinotti Slides |
| 09.40 - 09.50 | THE Y-ECCO/CLINCOM 2019 SURVEY ON POSTOPERATIVE CROHN’S DISEASE RECURRENCE SUGGESTS OVERTREATMENT WITH PROPHYLACTIC BIOLOGICAL THERAPY G. Dragoni Slides |
| 09.50 - 10.00 | A NEW QUESTIONNAIRE TO INVESTIGATE PATIENTS’ KNOWLEDGE OF RELEVANT ASPECTS OF INFLAMMATORY BOWEL DISEASE CLINICAL COURSE AND OUTCOMES: PRELIMINARY RESULTS. G. Zerboni Slides |
|
SESSION VIII: COMBO 3.0 |
|
| 11.15 - 11.35 | Future combinations in IBD: lessons from other specialties F. Caprioli Slides |
| 11.35 - 11.55 | Combination in HIV C.F. Perno Slides |
| 11.55 - 12.15 | Combination in Oncohematology L. Mazzarella Slides |